Comprehensive Analysis ofUGT1APolymorphisms Predictive for Pharmacokinetics and Treatment Outcome in Patients With Non–Small-Cell Lung Cancer Treated With Irinotecan and Cisplatin

This publication has 32 references indexed in Scilit:

• Genetic Variants in the UDP-glucuronosyltransferase 1A1 Gene Predict the Risk of Severe Neutropenia of Irinotecan
  Journal of Clinical Oncology, 2004
• UDP-Glucuronosyltransferase 1A7 Genetic Polymorphisms Are Associated with Hepatocellular Carcinoma in Japanese Patients with Hepatitis C Virus Infection
  Clinical Cancer Research, 2004
• Novel Functional Polymorphisms in the UGT1A7 and UGT1A9 Glucuronidating Enzymes in Caucasian and African-American Subjects and Their Impact on the Metabolism of 7-Ethyl-10-hydroxycamptothecin and Flavopiridol Anticancer Drugs
  The Journal of Pharmacology and Experimental Therapeutics, 2003
• UGT pharmacogenomics
  Pharmacogenetics, 2003
• Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer
  Gut, 2002
• UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity
  The Pharmacogenomics Journal, 2002
• Recommendation for Caution with Irinotecan, Fluorouracil, and Leucovorin for Colorectal Cancer
  New England Journal of Medicine, 2001
• The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism*^†
  Drug Metabolism Reviews, 2001
• Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.
  Journal of Clinical Investigation, 1998
• Identification of a Rat Oltipraz-inducible UDP-glucuronosyltransferase (UGT1A7) with Activity Towards Benzo(a)pyrene-7,8-dihydrodiol
  Journal of Biological Chemistry, 1997